Flunixin meglumine () antibody and antigen (hapten, BSA/OVA conjugated)

 Download 

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-SMT-199-Ag01	BSA-Flunixin meglumine	756
GMP-SMT-199-Ag02	OVA-Flunixin meglumine	756
GMP-SMT-199-Ab01	Anti-Flunixin meglumine mouse monoclonal antibody (mAb)	1953
GMP-SMT-199-Ab02	Anti-Flunixin meglumine mouse monoclonal antibody (mAb)	1953

Size： 1mg | 10mg | 100mg

Product Description

Cat No. of Products	GMP-SMT-199-Ag01
Product Name	BSA-Flunixin meglumine
Target/Biomarker	Flunixin meglumine ()
Expression platform	Synthetic
Isotypes	NA
Bioactivity validation	Flunixin meglumine () antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in level test of Inflammation/autoimmune/inflammatory disease () and related syndrome evaluation.
Tag	NA
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Flunixin meglumine () / OVA-Flunixin meglumine () is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-SMT-199-Ag02
Product Name	OVA-Flunixin meglumine
Target/Biomarker	Flunixin meglumine ()
Expression platform	Synthetic
Isotypes	NA
Bioactivity validation	Flunixin meglumine () antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in level test of Inflammation/autoimmune/inflammatory disease () and related syndrome evaluation.
Tag	NA
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Flunixin meglumine () / OVA-Flunixin meglumine () is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-SMT-199-Ab01, GMP-SMT-199-Ab02
Product Name	Anti-Flunixin meglumine mouse monoclonal antibody (mAb)
Target/Biomarker	Flunixin meglumine ()
Expression platform	Hybridoma
Isotypes	Mouse IgG
Bioactivity validation	Flunixin meglumine () antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in level test of Inflammation/autoimmune/inflammatory disease () and related syndrome evaluation.
Tag	mFc
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Flunixin meglumine () / OVA-Flunixin meglumine () is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

1. Flunixin Meglumine: Its Significance in In Vitro Diagnosis (IVD) Flunixin Meglumine, a non-steroidal anti-inflammatory drug (NSAID), holds a crucial and multifaceted role in the domain of in vitro diagnosis (IVD), particularly within the purview of veterinary medicine. Its emergence as a fundamental component in diagnostic applications stems from its remarkable attributes as a reference compound or calibration standard. In the intricate landscape of diagnostic assays, Flunixin Meglumine serves as the linchpin, responsible for establishing a foundational baseline response or concentration. This calibration process is pivotal for ensuring the precision, accuracy, and reliability of various diagnostic tests and assays that are indispensable in veterinary diagnostics. 2. The Imperative of Measuring Flunixin Meglumine The measurement of Flunixin Meglumine holds profound and multifarious significance, extending across several domains: Quality Control: Flunixin Meglumine stands as an embodiment of quality control in diagnostic tests. Its role is nothing short of indispensable, as it meticulously scrutinizes the integrity and functionality of diagnostic assays. By subjecting these assays to the discerning eye of Flunixin Meglumine, the scientific and clinical community ensures that every facet of the test, from reagents to instrumentation, is performing optimally. This stringent quality control process is an assurance of accurate and precise results, which form the bedrock of diagnostic decision-making. Assay Validation: In the intricate and meticulous development phases of diagnostic assays, Flunixin Meglumine steps into the spotlight as a reference compound of known concentration. This step is critical in the journey from assay conception to its practical application. Flunixin Meglumine is tasked with the role of validating the performance characteristics of the assay, ranging from accuracy to precision and linearity. The validation process ensures that the assay is indeed ready for deployment in real-world clinical or research scenarios. It instills confidence in the assay's ability to deliver consistent, trustworthy results across the spectrum of potential diagnostic applications. Research and Pharmacokinetics: Beyond the confines of diagnostic assays, Flunixin Meglumine assumes an equally significant role in research settings. Here, its measurement serves as a compass, guiding scientists and researchers through the intricate terrain of pharmacokinetics, distribution patterns, and elimination pathways within animal models. The insights gleaned from these investigations are instrumental in optimizing therapeutic protocols and refining treatment regimens. By understanding how Flunixin Meglumine behaves within the biological milieu, researchers can fine-tune dosages and administration schedules, thereby enhancing the efficacy and safety of NSAID treatments. Safety and Residue Monitoring: In the realm of veterinary medicine, the meticulous measurement of Flunixin Meglumine extends its reach into the domain of food safety and regulatory compliance. Ensuring that animal-derived products, such as meat and milk, are free from harmful residues of veterinary drugs is an absolute imperative. Flunixin Meglumine serves as the sentinel in this quest for safety, with precise measurement methodologies at its disposal. Through these methodologies, potential residues of Flunixin Meglumine are detected and quantified, thus safeguarding consumer safety and adhering to stringent regulatory standards. In summation, the measurement of Flunixin Meglumine is not a mere technicality but rather the lynchpin of precision and quality within the realm of in vitro diagnosis (IVD). Its role as a calibration standard and its multifaceted contributions to quality control, assay validation, research, and safety monitoring underscore its importance in the multifaceted world of veterinary medicine and diagnostics. Flunixin Meglumine ensures that diagnostic tests are reliable, research is precise, and the food supply remains safe, ultimately benefiting the well-being of animals and the assurance of public health.

About GDU